We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
Looks like consumer health isn’t the only franchise Pfizer is looking to shed. In a payoff for years of split-up talk, the pharma giant's got hive-off plans for its generics business, too.